October 2026 – Psychiatry AI: Real-Time AI Scoping Review

Depression RAISR4D

31/10/2026

An automated EEG-ECG framework for CAP-HRV analysis: enabling brain-heart coupling studies in sleep disorders

Front Physiol. 2026 Oct 16;17:1864664. doi: 10.3389/fphys.2026.1864664. eCollection 2026.ABSTRACTBACKGROUND: Multimodal sleep analysis typically requires separate processing pipelines for electroencephalography (EEG) and electrocardiography (ECG), which complicates...

Psychosis RAISR4D

31/10/2026

Interleukin pathway genotype and the grandiosity dimension of psychosis: a machine learning gene set analysis with unsupervised anomaly detection controls

Front Immunol. 2026 Oct 16;17:1936750. doi: 10.3389/fimmu.2026.1936750. eCollection 2026.ABSTRACTImmune involvement in psychosis is well supported, although most of the evidence comes from studies of negative...

Psychosis RAISR4D

31/10/2026

Resilience and clinical recovery in first-episode schizophrenia: a 10-year longitudinal study of clinically recovered, non-recovered, and healthy control participants

Front Psychiatry. 2026 Oct 16;17:1813256. doi: 10.3389/fpsyt.2026.1813256. eCollection 2026.ABSTRACTINTRODUCTION: Research on resilience in clinical recovery following first-episode schizophrenia (FES) remains limited, and few longitudinal studies...

Psychosis RAISR4D

31/10/2026

Sex differences in the association between Hcy levels and cognitive deficits among individuals with first-episode and drug-naive major depressive disorder

BMC Psychiatry. 2026 Aug 3;26(1):849. doi: 10.1186/s12888-026-08486-z.ABSTRACTOBJECTIVE: Previous studies have shown that elevated homocysteine (Hcy) levels are associated with cognitive deficits in first-episode and drug-naive...

Psychosis RAISR4D

31/10/2026

Implementation strategies for digital relapse prevention in schizophrenia identified during a randomized controlled trial

NPJ Digit Med. 2026 Oct 30;9(1):827. doi: 10.1038/s41746-026-03435-2.ABSTRACTDigital mental health technologies hold promise, yet their integration into routine care remains challenging. This study reports findings...

Psychiatry RAISR4D

31/10/2026

Psychological support for depression and anxiety across chronic illness contexts: a comparative evaluation of three general-purpose AI chatbots

Front Psychiatry. 2026 Oct 16;17:1962615. doi: 10.3389/fpsyt.2026.1962615. eCollection 2026.ABSTRACTBACKGROUND: Digital mental health tools, including general-purpose artificial intelligence (AI) chatbots, may provide accessible and low-threshold psychological...

Psychiatry RAISR4D

31/10/2026

Psychometric properties of the self-reflection and insight scale (revised) in German-speaking clinical psychology trainees

Front Psychol. 2026 Oct 16;17:1733344. doi: 10.3389/fpsyg.2026.1733344. eCollection 2026.ABSTRACTINTRODUCTION: Self-reflection is a core competency for clinical psychologists and mental health professionals. Given its essential role...

Psychiatry RAISR4D

31/10/2026

Real-world clinical outcomes under intravenous and subcutaneous esketamine protocols for treatment-resistant depression: a multicenter, retrospective study

Front Psychiatry. 2026 Oct 16;17:1963841. doi: 10.3389/fpsyt.2026.1963841. eCollection 2026.ABSTRACTBACKGROUND: Esketamine is a promising therapeutic option for treatment-resistant depression (TRD). Intravenous (IV) administration is the most...

Psychiatry RAISR4D

31/10/2026

Context presentation and native conversation structure in large language model responses to escalating suicide risk: a controlled multimodel evaluation

Front Psychiatry. 2026 Oct 16;17:1962098. doi: 10.3389/fpsyt.2026.1962098. eCollection 2026.ABSTRACTBACKGROUND: Large language models are increasingly used for informal mental health support, yet their safety during escalating...

Psychiatry RAISR4D

31/10/2026

Culturally adapted psychoeducation for bipolar disorder: a multicentre, assessor-masked, randomised controlled trial

EClinicalMedicine. 2026 Oct 24;101:104271. doi: 10.1016/j.eclinm.2026.104271. eCollection 2026 Nov.ABSTRACTBACKGROUND: Adjunctive psychoeducation can reduce recurrence of mood episodes in bipolar disorder (BD), but evidence from low-resource...

Psychiatry RAISR4D

31/10/2026

Dual-site multifocal HD-tDCS modulates bilingual language control via brain activity and connectivity

Cogn Neurodyn. 2026 Dec;20(1):210. doi: 10.1007/s11571-026-10582-5. Epub 2026 Oct 29.ABSTRACTBilinguals rely on language control mechanisms to manage cross-language interference. Interactions between the pre-supplementary motor area...

Psychiatry RAISR4D

31/10/2026

Factors enabling and hindering students’ career interest in nursing: a scoping review of four decades of evidence (1984-2025)

J Res Nurs. 2026 Oct 28:17449871261486791. doi: 10.1177/17449871261486791. Online ahead of print.ABSTRACTBACKGROUND: Global nursing shortages have renewed attention to recruitment, yet most initiatives begin after...

Psychiatry RAISR4D

31/10/2026

Sleep and Cognitive Performance: Exploring Benzodiazepine Receptor Agonist Use, Insomnia Symptoms, and Obstructive Sleep Apnea

Ageing Int. 2026;51(4):48. doi: 10.1007/s12126-026-09684-6. Epub 2026 Oct 29.ABSTRACTOBJECTIVES: We hypothesized that benzodiazepine/z-drug (BZRA) dose, insomnia symptoms, and obstructive sleep apnea (OSA) risk are associated...

Psychiatry RAISR4D

31/10/2026

Oral Esketamine Maintenance Treatment for Treatment-Resistant Depression: Clinical Outcomes During an Off-Label Treatment Program

Depress Anxiety. 2026 Oct 29;2026:8320239. doi: 10.1155/da/8320239. eCollection 2026.ABSTRACTKetamine and esketamine maintenance treatment show promise in maintaining initial antidepressant effects, yet further research is needed...

Obsessive-Compulsive Disorder RAISR4D

31/10/2026

Deep brain stimulation of the superolateral medial forebrain bundle in obsessive-compulsive disorder: Outcomes of symptom domains and their predictive value for treatment efficacy

Neurotherapeutics. 2026 Oct 30;24(1):e01094. doi: 10.1016/j.neurot.2026.e01094. Online ahead of print.ABSTRACTDeep Brain Stimulation (DBS) of the superolateral medial forebrain bundle (slMFB) has shown promise in treatment-resistant...